Back to School: How biopharma can reboot drug development. Access exclusive analysis here

GPC seeking $117.4M on NASDAQ

GPC (FSE:GPC) filed to raise $117.4 million through the sale of

Read the full 118 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE